The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig

This publication has 35 references indexed in Scilit:

• The mechanism of the force enhancement by mgADP under simulated isChaemic conditions in rat cardiac myocytes
  The Journal of Physiology, 2002
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
  The Lancet, 2002
• Compartmentation of G Protein-Coupled Signaling Pathways in Cardiac Myocytes
  Annual Review of Pharmacology and Toxicology, 2001
• Binding of Levosimendan, a Calcium Sensitizer, to Cardiac Troponin C
  Journal of Biological Chemistry, 2001
• Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca²⁺ current in rat ventricular myocytes
  British Journal of Pharmacology, 1999
• Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?1
  European Journal of Cardio-Thoracic Surgery, 1998
• Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer
  General Pharmacology: The Vascular System, 1996
• Influence of Isoproterenol on Contractile Protein Function, Excitation-Contraction Coupling, and Energy Turnover of Isolated Nonfailing Human Myocardium
  Journal of Molecular and Cellular Cardiology, 1994
• Effects of a Cardiotonic Quinolinone Derivative Y-20487 on the Isoproterenol-Induced Positive Inotropic Action and Cyclic AMP Accumulation in Rat Ventricular Myocardium
  Journal of Cardiovascular Pharmacology, 1992
• Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles
  European Journal of Pharmacology: Molecular Pharmacology, 1992